ALAnna A. Lenyushkina

Anna A. Lenyushkina

*This is an algorithmically generated author record based on publicly available information.

Anna A. Lenyushkina has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Irina V. Nikitina

    National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow

    13 shared publications
  • Olga A. Krogh-Jensen

    V.I. Kulakov National Medical Research Center for Obstetrics Gynecology and Perinatology, Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia

    12 shared publications
  • Dmitriy N. Degtyarev

    National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow

    7 shared publications
  • Ekaterina I. Savelyeva

    Sechenov First Moscow State Medical University

    5 shared publications
  • Anna Vladimirovna Degtyareva

    National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow

    4 shared publications
  • Viktor V. Zubkov

    ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Министерства здравоохранения Российской Федерации

    4 shared publications

Latest Publications

  • Non-immune hydrops fetalis caused by parvovirus B19 in a neonate – successful management

    by I.V. Nikitina, A.A. Lenyushkina, E.I. Savelyeva, A.F. Pupysheva, M.A. Shcherbakov, V.V. Zubkov, D.N. Degtyarev

  • Open Access

    Longitudinal Fecal Short-Chain Fatty Acid Trajectories in Preterm Infants with Early-Onset Neonatal Sepsis: A Pilot Study

    by Evgenii Kukaev, Olga Krogh-Jensen, Natalia Starodubtseva, Alisa Tokareva, Irina Nikitina, Anna Lenyushkina, Vladimir Frankevich, Gennady Sukhikh

    Background: Early-onset neonatal sepsis (EONS), defined as systemic infection occurring within the first 72 hours of life, remains a major cause of morbidity and mortality in preterm infants. Increasing evidence indicates that the gut may play an active role in systemic inflammation, yet the temporal behavior of fecal short-chain fatty acids (SCFAs) during EONS has not been characterized. SCFAs and branched-chain fatty acids (BCFAs) are key microbial metabolites involved in epithelial maturation and immune regulation and may provide a non-invasive window into early inflammatory vulnerability. Methods: This pilot prospective longitudinal cohort study enrolled 49 preterm infants (≤32 weeks’ gestation) originally identified as at high risk for necrotizing enterocolitis (NEC) and subsequently stratified into EONS and non-sepsis groups. Serial stool samples were collected at predefined timepoints (TPs; TP1 ≈ 3 days of life [DoL], TP2 ≈ 7 DoL, TP3 ≈ 14 DoL, TP4 ≈ 21 DoL, and TP5 ≈ 28 DoL). Samples were analyzed using gas chromatography–mass spectrometry (GC–MS) to quantify a panel of 12 SCFAs, including BCFAs and medium-chain fatty acids (MCFAs). Both absolute concentrations and relative fractions were evaluated, with emphasis on ratio-based metrics (e.g., acetic/propionic acid ratio) and timepoint-specific group contrasts, complemented by partial least squares discriminant analysis (PLS–DA). Results: At the earliest sampling window (TP1), infants with EONS exhibited distinct early changes in SCFA composition, including a significantly lower median relative fraction of acetic acid (86.6% vs. 94.5% in non-sepsis), while several non-acetate components—including propionic, valeric, and branched-chain acids—were relatively enriched. Acetate-to-non-acetate ratios were markedly reduced in EONS (e.g., acetic/propionic and acetic/isobutyric ratios), indicating an early shift away from acetate dominance. PLS–DA at TP1 demonstrated partial separation between groups, with acetic-acid depletion and non-acetate enrichment among the strongest contributors to discrimination. By later TPs, these early differences narrowed to a small subset of BCFA-related ratios and largely attenuated by the end of the first month. Conclusions: In this pilot cohort of preterm infants, EONS was associated with early, structured alterations in fecal SCFA profiles, characterized by reduced acetic-acid dominance and relative enrichment of non-acetate acids. Dynamic, ratio-based assessment proved more informative than absolute concentrations alone, revealing transient intestinal metabolic signatures accompanying systemic infection. These findings provide the first longitudinal evidence of gut metabolic involvement in EONS and lay the groundwork for larger, multi-center studies integrating SCFA trajectories with microbiome and immune profiling to refine early risk stratification for systemic infection in high-risk neonatal populations.


  • Open Access

    Gut microbiota and short-chain fatty acids in the pathogenesis of necrotizing enterocolitis in very preterm infants

    by Evgenii N. Kukaev, Alisa O. Tokareva, Olga A. Krogh-Jensen, Anna A. Lenyushkina, Nataliia L. Starodubtseva

    The development of a symbiotic gut ecosystem is a crucial step in postnatal adaptation. The gut microbiome of very preterm infants is characterized by an overall instability, reduced microbial diversity, and a predominance of Gram-negative Proteobacteria, all factors associated with an increased risk of necrotizing enterocolitis (NEC). Short-chain fatty acids (SCFAs) are the key bacterial metabolites that are essential for maintaining intestinal homeostasis, supporting immune development, enhancing intestinal barrier integrity, and reducing inflammation. This review examines the role of gut microbiota and SCFAs in neonatal NEC, with a focus on potential diagnostic and therapeutic strategies. Clinical studies have consistently demonstrated a significant decrease in total SCFA levels and individual bacterial metabolites in preterm infants with NEC. This finding has been corroborated by various experimental models. Clarification of the role of SCFAs in NEC pathogenesis, determination of their diagnostic utility, and assessment of the feasibility of developing comprehensive pro- and postbiotic formulations require multi-center, multi-omics investigations that include a large cohort of very preterm infants.


  • Open Access

    Longitudinal Fecal Short-Chain Fatty Acid Trajectories in Preterm Infants with Early-Onset Neonatal Sepsis: A Pilot Study

    by Evgenii Kukaev, Olga Krogh-Jensen, Natalia Starodubtseva, Alisa Tokareva, Irina Nikitina, Anna Lenyushkina, Vladimir Frankevich, Gennady Sukhikh

    Background: Early-onset neonatal sepsis (EONS), defined as systemic infection occurring within the first 72 hours of life, remains a major cause of morbidity and mortality in preterm infants. Increasing evidence indicates that the gut may play an active role in systemic inflammation, yet the temporal behaviour of fecal short-chain fatty acids (SCFAs) during EONS has not been characterised. SCFAs and branched-chain fatty acids (BCFAs) are key microbial metabolites involved in epithelial maturation and immune regulation and may provide a non-invasive window into early inflammatory vulnerability. Methods: This pilot prospective longitudinal cohort study enrolled preterm infants (⩽ 32 weeks’ gestation) originally identified as at high risk for necrotizing enterocolitis (NEC) and subsequently stratified into EONS and non-sepsis groups. Serial stool samples were collected at predefined timepoints (TPs; TP1 ≈ 3 days of life [DoL], TP2 ≈ 7 DoL, TP3 ≈ 14 DoL, TP4 ≈ 21 DoL, and TP5 ≈ 28 DoL). Samples were analysed using gas chromatography–mass spectrometry (GC–MS) to quantify a panel of 12 SCFAs, including BCFAs and medium-chain fatty acids (MCFAs). Both absolute concentrations and relative fractions were evaluated, with emphasis on ratio-based metrics (e.g., acetic/propionic acid ratio) and timepoint-specific group contrasts, complemented by partial least squares discriminant analysis (PLS–DA). Results: At the earliest sampling window (TP1), infants with EONS exhibited a broad redistribution of the fecal SCFA pool. The median relative fraction of acetic acid was significantly lower in EONS (86.6% vs. 94.5% in non-sepsis), while several non-acetate components—including propionic, valeric, and branched-chain acids—were relatively enriched. Acetate-to-non-acetate ratios were markedly reduced in EONS (e.g., acetic/propionic and acetic/isobutyric ratios), indicating an early shift away from acetate dominance. PLS–DA at TP1 demonstrated partial separation between groups, with acetic-acid depletion and non-acetate enrichment among the strongest contributors to discrimination. By later TPs, these early differences narrowed to a small subset of BCFA-related ratios and largely attenuated by the end of the first month. Conclusions: In this pilot cohort of preterm infants, EONS was associated with early, structured alterations in fecal SCFA profiles, characterised by reduced acetic-acid dominance and relative enrichment of non-acetate acids. Dynamic, ratio-based assessment proved more informative than absolute concentrations alone, revealing transient intestinal metabolic signatures accompanying systemic infection. These findings provide the first longitudinal evidence of gut metabolic involvement in EONS and lay the groundwork for larger, multi-centre studies integrating SCFA trajectories with microbiome and immune profiling to refine early risk stratification for systemic infection in high-risk neonatal populations.


  • Open Access

    The impact of the number of intrauterine donor erythrocyte transfusions on laboratory parameters in newborns with Rh-mediated hemolytic disease

    by E.V. Uretskaya, A.A. Lenyushkina, O.A. Krogh-Jensen, P.A. Uvarenkova

    Влияние количества внутриутробных трансфузий донорских эритроцитов на лабораторные показатели, выявляемые при обследовании новорожденных с

  • Open Access

    Comparison of methods for assessing the psychomotor development of preterm infants born with extremely low birth weight and very low birth weight

    by T.K. Tsechoeva, Yu.A. Burdukova, A.A. Lenyushkina, D.N. Degtyarev

    Сопоставление методов оценки психомоторного развития недоношенных детей, родившихся с экстремально низкой и очень низкой массой тела


  • Open Access

    Variant in the ATP1A3 gene: a review of current literature and the development of CAPOS syndrome in a preterm infant – a clinical case report

    by I.V. Nikitina, I.M. Amelin, L.V. Ushakova, A.A. Dokshukina, A.A. Lenyushkina, V.V. Zubkov

    Вариант в гене АТР1А3 : обзор современных литературных данных. Формирование CAPOS-синдрома у глубоконедоношенного ребенка. Клиническое наблюдение


  • Open Access

    The value of plasma cytokines within the early neonatal period for predicting necrotizing enterocolitis in preterm infants

    by I.V. Nikitina, A.A. Lenyushkina, O.A. Krogh-Jensen, A.F. Pupysheva, L.V. Krechetova, E.V. Inviyaeva, E.I. Savelyeva, V.V. Zubkov, D.N. Degtyarev, E.N. Baybarina

    Прогностическая значимость исследования уровня цитокинов плазмы крови в раннем неонатальном периоде в отношении некротизирующего энтероколита у


  • Open Access

    Current issues of evaluation of the blood coagulation system in intensive care in newborn children. Literature review

    by L.A. Morozov, A.M. Boldyreva, A.A. Lenyushkina, E.N. Balashova, D.N. Degtyarev

    Актуальные вопросы оценки свертывающей системы крови в интенсивной терапии новорожденных. Обзор литературы

  • Open Access

    Recurrent necrotizing enterocolitis: predictors, biological markers, diagnostic signs, and therapeutic approaches – a year-long case study

    by I.V. Nikitina, A.A. Lenyushkina, O.A. Krogh-Jensen, E.I. Savelyeva, E.I. Dorofeeva, Yu.L. Podurovskaya, V.V. Zubkov, D.N. Degtyarev

    Сложный клинический случай рецидивирующего некротизирующего энтероколита: анализ предикторов, биологических маркеров, инструментальных признаков,